OPC-249

· Otsuka Pharmaceutical Co., Ltd.

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for OPC-249, covering 2014-01-30 to 2014-01-30. Get the full timeline:

Most recent: Clinical Trial Update: Dose-ranging Trial of OPC-249 Powder Inhalation in Patients With Pain Due to Osteoporosis [Phase 2]